Author:
Javadpour N.,Lalehzarian M.
Abstract
During the past two decades, a dramatic improvement has been made in the treatment of testicular germ cell tumor. This progress has been dueto finding more efficacious systemic chemotherapeutic agents and the availability of specific and sensitive biologic tumor markers to detect early recurrence and monitor the therapy. In this review, i will update my 15 years of experience in establishing and utilization of these serum and cell markers in testicular cancer.
Publisher
Revista Brasileira De Cancerologia (RBC)
Reference12 articles.
1. Javadpour N, Thomas W, and Busch 1 M - Production and treatment of testicuar teratocarcinoma induced by genital ridge transplantation. Journal of Urology, 1972, 105. 534.
2. Avelev GI - Alpha-protein in oncogenesis and Is assoclatiori with malignant tumors Advances in Cancer Research, 1971; 14: 295-359.
3. Vaitukaitis JL, Braunstein GD and Ross GT - A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone Am J ObsteI Gynecol, 1972; 113: 751
4. Waldmann IA, Mclntire KR - The use of a radioimmunoassay for aIphafetoprotein in lhe diagnosis of malignancy. Cancer, 1974; 34 1510.
5. Javadpour N, Mclntire KR, Waldmann IA - lmmunochemical determination of human chorionic gonadotropin (hCG) and alphafetoprotein (AFP) in sera and tumors of patients with testicular cancer. National Cancer Institute Monographs, 1978; 49. 209-213.